Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study.

about

Alterations in serum kynurenine pathway metabolites in individuals with high neocortical amyloid-β load: A pilot study.

Item

http://www.wikidata.org/entity/Q55071408

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Alterations in serum kynurenin ...... amyloid-β load: A pilot study.

@en

Alterations in serum kynurenin ...... amyloid-β load: A pilot study.

@nl

type

Item

label

Alterations in serum kynurenin ...... amyloid-β load: A pilot study.

@en

Alterations in serum kynurenin ...... amyloid-β load: A pilot study.

@nl

prefLabel

Alterations in serum kynurenin ...... amyloid-β load: A pilot study.

@en

Alterations in serum kynurenin ...... amyloid-β load: A pilot study.

@nl

P1476

Alterations in serum kynurenin ...... amyloid-β load: A pilot study

@en

P2093

Candice ManYan

http://www.w3.org/2001/XMLSchema#string

Ian James

http://www.w3.org/2001/XMLSchema#string

Kevin Taddei

http://www.w3.org/2001/XMLSchema#string

Preeti Dave

http://www.w3.org/2001/XMLSchema#string

P2860

MR-less surface-based amyloid assessment based on 11C PiB PET

“Mini-mental state”

Kynurenines in the mammalian brain: when physiology meets pathology

Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus

Kynurenine and its metabolites in Alzheimer's disease patients

The role of tryptophan 2,3-dioxygenase in the hormonal control of tryptophan metabolism in isolated rat liver cells. Effects of glucocorticoids and experimental diabetes

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria.

Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment.

P304

8008

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-25968-7

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pratishtha Chatterjee

P577

2018-05-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29789640

http://www.w3.org/2001/XMLSchema#string

P932

5964182

http://www.w3.org/2001/XMLSchema#string